Skip to Content

Artemis Therapeutics Inc - Stock Quote ATMS

Rating as of

Morningstar's Artemis Therapeutics Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Artemis Therapeutics Inc's Company Profile

Business Description

Artemis Therapeutics Inc is exploring strategic alternatives. It is seeking a business combination candidate that would bring revenue and/or asset value to the company.

18 East 16th Street, Suite 307
New York, NY, 10003
T +1 646 233-1454
Sector Financial Services
Industry Shell Companies
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2021
Stock Type Slow Growth
Employees 1